FIRST JAK INHIBITOR SPECIFICALLY FOR ALOPECIA AREATA APPROVED IN THE UK!!
Tommy and Frank discuss the breaking news that the National Institute for Health and Care Excellence (NICE) has made the decision to recommend the JAK inhibitor medicine ritlecitinib (Litfulo) for routine commissioning from the NHS. This recommendation is for treatment of severe alopecia areata in patients aged 12 and over.
Tommy shares his personal experience with the NHS, and how tremendous this news is for those in the UK with alopecia.
Congratulations to Sue Schilling and Alopecia UK for all their advocacy work regarding this decision!
Connection is everything!
Remember to rate, review, subscribe and share!
Alopecia Connection Linktree
Alopecia Connection Website
*Discussions on Alopecia Connection are from the personal perspectives and experiences of its host and guests, and should be considered that. Any personal medical decisions should only be made after consultation with one's health care provider.
FIRST JAK INHIBITOR SPECIFICALLY FOR ALOPECIA AREATA APPROVED IN THE UK!!
Tommy and Frank discuss the breaking news that the National Institute for Health and Care Excellence (NICE) has made the decision to recommend the JAK inhibitor medicine ritlecitinib (Litfulo) for routine commissioning from the NHS. This recommendation is for treatment of severe alopecia areata in patients aged 12 and over.
Tommy shares his personal experience with the NHS, and how tremendous this news is for those in the UK with alopecia.
Congratulations to Sue Schilling and Alopecia UK for all their advocacy work regarding this decision!
Connection is everything!
Remember to rate, review, subscribe and share!
Alopecia Connection Linktree
Alopecia Connection Website
*Discussions on Alopecia Connection are from the personal perspectives and experiences of its host and guests, and should be considered that. Any personal medical decisions should only be made after consultation with one's health care provider.